AzTrials
AzTrials

Procedural AnxietyViVANCT05275621

Virtual Reality as a Substitute to Pharmacological Sedation During PICC Placement in Pediatric Patients

A study testing Virtual Reality and PICC positioning in people with Procedural Anxiety, run by ASST Fatebenefratelli Sacco at 6 sites in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In pediatric patients Peripherally Inserted Central Catheters (PICC) insertion requires pharmacological sedation provided by an anesthesiologist, which poses a certain degree of risks. Read more about this study

Who is it for?
Ages 7 to 14 years
Conditions the study is for
Procedural Anxiety
What is being tested?
Virtual Reality and PICC positioning
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
6 sitesItaly
Study dates
Mar 2022to Apr 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 14 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Aged between 7 and 14 years old
  • Indication for Vascular Access Device placement with the need for sedation
  • Signed informed consent form by the subject's caregivers (commonly both parents)

Who cannot join

  • Inability to fill in the rating scales
  • Inability to experience Virtual Reality with TOMMI (e.g., eye diseases)
  • Presence of disease that produces complete immobility
  • Refusal to sign informed consent

Trial locations and contacts

6 sites in 1 country.

6 sites in 1 country

Italy6 sites
  • Spedali Civili di Brescia

    Brescia, BS, 25123

    Stefano Benvenuti, MD, +39 030996201

  • Ospedale Pediatrico Istituto Gianna Gaslini

    Genova, GE

    Michele Wolfler, MD, +39 010 56362445, segranestesia@gaslini.org

  • Ospedale dei Bambini "Vittore Buzzi"

    Milan, MI, 20100

  • Fatebenefratelli Hospital

    Milan, MI, 20121

    Marco Gemma, MD, +39 0263632414, gemma.marco@hsr.it

  • AORN Pausilipon

    Naples

    Federica Pitta, 081 2205111, santobonopausilipon@pec.it

  • Regina Margherita Hospital

    Torino, 10126

    Giorgio Ivani, MD, +39 0113135937, gioivani@libero.it

Other trials in Italy

About this study

Official title: Virtual Reality for Vascular Access: a Multicenter Feasibility Study

In pediatric patients Peripherally Inserted Central Catheters (PICC) insertion requires pharmacological sedation provided by an anesthesiologist, which poses a certain degree of risks. In enrolled subjects, PICC insertion is tried without drug sedation, using an immersive virtual reality experience as a distraction technique. If the subjects is not able to keep still or if pain levels are too high, the virtual reality attempt is stopped and standard drug sedation is provided by a pediatric anesthesiologist.

Aim of study is to evaluate the feasibility of the PICC insertion procedure using the virtual reality distraction technique. The investigators hypothesize that this could avoid the need for drug sedation, reducing sedation-related risks and costs and reduce anxiety and pain related to the procedure.

Read the detailed description

A PICC is a central intravenous catheter inserted through a peripheral vein of the upper arm. In pediatric subjects, the insertion usually requires pharmacological sedation because of the anxiety and the pain experienced by the children during the procedure. Sedation inevitably poses a certain risk, particularly of airway obstruction, respiratory drive reduction en hemodynamic instability. Finally, costs are sensibly higher when sedation is required, since, besides the need for drugs and devices (e.g. for monitoring and airway management), an experienced pediatric anesthesiologist and a nurse are needed for providing sedation.

The investigators hypothesize that the application of virtual reality to children undergoing PICC placement, could avoid the need for drug sedation. This would result in a reduction in anxiety and pain related to the procedure and a potential reduction in costs. Moreover any possible adverse event related to pharmacological sedation would be avoided.

The material used for providing the virtual reality experience consist of a commercially available virtual reality headset (Oculus Quest 2 by Facebook Technologies ltd) and a dedicated software called "TOMMI" (developed by Softcare Studios Srl). Subjects find themselves in a virtual environment where they can play different games. The game which was chosen is called "drums", optimized for enhanced sensorimotor engagement and distraction from acute sensations such as pain. In this game subjects see three different drums they can beat with a "magic wand" they can control by moving the handheld controller. Geometric shapes in different colors fall from above indicating which drum to beat and at which time.

This game was chosen for several reasons: it can be played for sufficient time without getting excessively boring or tiring (the procedure usually lasts about half an hour); it can be easily played both by younger and older children; it does not require wide movements either of the head or of the upper limb holding the controller, and the opposite upper limb isn't involved in any way. Thus, distracting or even dangerous movements of the subject can be avoided, ensuring the successful completion of the procedure.

Subjects will be enrolled by the investigators in each participating center according to the inclusion and exclusion criteria. To participate informed consent has to be acquired in written form from both the caregivers and, if able to do so, also by the subjects.

Before the procedure multiple variables will be recorded to draw a baseline of each enrolled subject. These will include age, sex, BMI, previous experiences of sedation and of venipuncture and a psychological and behavioral profile using a self-administered questionnaire for caregivers (Child Behaviour Checklist - Achenbach ASEBA).

At the start of the procedure the Investigators will explain to the subject the use of the Virtual Reality viewer and will help him in positioning it. Patients will be monitored with continuous ECG and SpO2. All PICC placements will be carried out by trained and experienced implanter, in a dedicated room and under full barrier precautions. A pediatric anesthesiologist will always be available on site.

While arranging the sterile field, and at least for five minutes, the implanter will let the patient get fully immersed in the virtual environment. Meanwhile, the implanter will check that the child has correctly understood how to play the game.

In each patient, the site of insertion will be chosen after proper echographic evaluation of the vascular anatomy following the RaPeVA protocol as recommended by the Italian Vascular Access Society (IVAS). Entry site will be chosen in the middle third of the upper arm or in the "green zone" after the Zone Insertion Method™ by Robert Dawson. Venipuncture will be performed under ultrasound guidance and the catheter will be placed using a modified Seldinger technique over a tearaway introducer. Before introducing the dilator, the provider will inject the area with a local anesthetic and performed a small skin incision with a scalpel. Tip guidance and location was achieved through continuous intracavitary ECG.

Standard procedural sedation will be provided for those who won't tolerate the procedure using only the Virtual Reality immersion. No kind of active or passive restraint will be enforced during the whole procedure, the patients will be required to hold still for the whole time just by themselves.

Data will be analyzed with the R software in its latest version - Copyright (C) 2021 The R Foundation for Statistical Computing Platform: R Core Team (2021). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/.

Continuous data will be reported as mean and standard deviation, categorical as number (percentage).

The investigators consider the accomplishment of the PICC placement procedure as the primary endpoint of our study (a dichotomous N/Y variable).

The procedure with the virtual reality is expected to be successful in the majority of all cases. Hence, in calculating the sample size (without finite population correction), the investigators consider an expected proportion of accomplishment of 0.95 with a precision (half width of the 95 percent confidence interval) of 0.04. This yields a sample size of 120 patients.

Being tested
Virtual Reality, PICC positioning

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual RealityDevice

    A Virtual Reality game is provided through a headset. Subjects play in a virtual environment. Positioning of the headset occurs before starting the procedure and is maintained throughout the procedure. The headset used will be "Oculus Rift 2 by Facebook Tech. ltd.". The software is designed specifically for the purpose by Softcare Studios. The "game" played is called "Drums".

  • PICC positioningProcedure or surgery

    A PICC is inserted under ultrasound guidance through a modified Seldinger technique in a deep vein of the upper arm. The skin is infiltrated with 0.5-1ml 2% lidocaine before dilation of the skin. Tip guidance and positioning is achieved through intracavitary ECG.

Study groups in NCT05275621
Study groupRoleWhat they receive
Subjects requiring PICCExperimentalSubjects requiring a PICC. Positioning is first tried under Virtual Reality distraction. If failure (movements or discomfort) standard procedural sedation is applied. No kind of physical restraint is allowed.
Receives: Device: Virtual Reality; Procedure: PICC positioning

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in baseline Pain assessed by the Wong-Baker FACES Scale

    The Wong-Baker FACES Scale is a validated scale used to assess the experienced pain in subjects from three years of age. It consists of six different faces: the first represents no pain at all and is described by the words "No Hurt" and the last one represents a pain score of "10 out of 10" on a numeric rating scale, and indicates "hurts worst."

    Measured: Baseline and Five minutes after the procedure has been completed

  2. Change in baseline Anxiety assessed by a numeric rating scale

    Anxiety is assessed through a numeric rating scale ranging from zero representing no anxiety at all, up to ten representing the worst anxiety level.

    Measured: Baseline and Five minutes after the procedure has been completed

Secondary outcomes (3)
  1. Duration of the procedure

    time for catheter positioning is measured

    Measured: During the procedure

  2. Subject's satisfaction

    Subject's satisfaction is measured through a numeric rate scale from 0 to 10 with 0 indicating extreme discomfort and 10 indicating absolute satisfaction.

    Measured: through study completion, an average of three months

  3. Staff satisfaction

    Staff satisfaction on the procedure is evaluated through a numeric rate scale from 0, indicating not satisfied at all, to 10, very satisfied.

    Measured: After study completion, expected six months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Mar 2022
  2. Study startMar 2022 (estimated)
  3. Primary completionApr 2022 (estimated)
  4. Study completionApr 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05275621
Sponsor's protocol ID
2021/ST/291
Acronym
ViVA
Status last verified
Mar 2022
First submitted
14 Feb 2022
Last updated
11 Mar 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality and PICC positioning in people with Procedural Anxiety, run by ASST Fatebenefratelli Sacco at 6 sites in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Marco Gemma, MD (+39 0263632414, marco.gemma@asst-fbf-sacco.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in baseline Pain assessed by the Wong-Baker FACES Scale (time frame: Baseline and Five minutes after the procedure has been completed). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in